XCL1 enhances regulatory activities of CD4+CD25 highCD127low/- T cells in human allergic asthma

Journal of Immunology

Volumn 181, Issue 8, 2008, Pages 5386-5395

  Nguyen, Khoa D ^a   Fohner, Alison ^a   Booker, Jerome D ^a   Dong, Chen ^a   Krensky, Alan M ^b   Nadeau, Kari C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; INTERLEUKIN 7 RECEPTOR; LYMPHOTACTIN; OMALIZUMAB; SALBUTAMOL; SALMETEROL; GAMMA CHEMOKINE; INTERLEUKIN 7 RECEPTOR ALPHA; XCL1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ CD25+ CD127+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTOTOXICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; ASTHMA; BIOSYNTHESIS; CELLULAR IMMUNITY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; METABOLISM;

ASTHMA; CHEMOKINES, C; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 54049137604     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.8.5386     Document Type: Article

References (34)

1. Lee, T. H. 1987. Interactions between alveolar macrophages, monocytes, and granulocytes: implications for airway inflammation. Am. Rev. Respir. Dis. 135: S14-S17.
2. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304.
3. Akbari, O., P. Stock, R. H. DeKruyff, and D. T. Umetsu. 2003. Role of regulatory T cells in allergy and asthma. Curr. Opin. Immunol.15: 627-633. (Pubitemid 37434069)
4. + regulatory T cells. Semin. Immunol. 16: 89-98.
5. Grindebacke, H., K. Wing, A. C. Andersson, E. Suri-Payer, S. Rak, and A. Rudin. 2004. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin. Exp. Allergy 34: 1364-1372. (Pubitemid 39233690)
6. + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363: 608-615.
7. + regulatory T cells. J. Exp. Med. 203: 2649-2660.
8. + T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 202: 1549-1561.
9. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
10. + regulatory T cells. Nat. Immunol. 4: 330-336.
11. Wei, S., I. Kryczek, and W. Zou. 2006. Regulatory T-cell compartmentalization and trafficking. Blood 108: 426-431.
12. + regulatory T cells in MRL/lpr mice. Arthritis Res. Ther. 9: R15.
13. + regulatory T cells in gastric cancer. Int. J. Cancer 122: 2286-2293.
14. Ishida, T., and R. Ueda. 2006. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci. 97: 1139-11116
15. Hasegawa, H., A. Inoue, M. Kohno, J. Lei, T. Miyazaki, O. Yoshie, M. Nose, and M. Yasukawa. 2008. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. Gene Ther. 15: 171-182. (Pubitemid 351175219)
16. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, and T. J. Schall. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266: 1395-1399.
17. +, and NK cells. J. Interferon Cytokine Res. 5: 573-582.
18. + T cells and intratumoral lymphotactin transgene expression. Cancer Res. 62: 2043-2051.
19. Huang, H., and J. Xiang. 2004. Synergistic effect of lymphotactin and interferon γ-inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors. Int. J. Cancer 109: 817-825. (Pubitemid 38500737)
20. + T cells. Blood 97: 2205-2212.
21. Rumsaeng, V., H. Vliagoftis, C. K. Oh, and D. D. Metcalfe. 1997. Lymphotactin gene expression in mast cells following Fcε receptor I aggregation: modulation by TGF-β, IL-4, dexamethasone, and cyclosporin A. J. Immunol. 158: 1353-1360. (Pubitemid 127469961)
22. Mekori, Y. A., and D. D. Metcalfe. Mast cell-T cell interactions. 1999. J. Allergy Clin. Immunol. 104: 517-523.
23. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388-392.
24. Grossman, W. J., J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589-601.
25. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269: 1727-1730.
26. Makino, Y., D. N. Cook, O. Smithies, O. Y. Hwang, E. G. Neilson, L. A. Turka, H. Sato, A. D. Wells, and T. M. Danoff. 2002. Impaired T cell function in RANTES- deficient mice. Clin. Immunol. 102: 302-309. (Pubitemid 34259264)
27. Schuh, J. M., K. Blease, and C. M. Hogaboam. 2002. The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in mice. FASEB J. 16: 228-230.
28. Castro, M., S. R. Bloch, M. V. Jenkerson, S. DeMartino, D. L. Hamilos, R. B. Cochran, X. E. Zhang, H. Wang, J. P. Bradley, K. B. Schechtman, and M. J. Holtzman. 2004. Asthma exacerbation after glucocorticoid withdrawal re- flects T cell recruitment to the airway. Am. J. Respir. Crit. Care Med. 169: 842-849. (Pubitemid 38402461)
29. + T cell generation with enhanced granzyme B expression by IL-27. J. Immunol. 175: 1686-1693.
30. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-1579.
31. Tsuji-Takayama, K., M. Suzuki, M. Yamamoto, A. Harashima, A. Okochi, T. Otani, T. Inoue, A. Sugimoto, R. Motoda, F. Yamasaki, et al. 2007. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT. Exp. Hematol. 36: 181-192.
32. + T cells derived from the majority of atopic donors are able to suppress TH1 andTH2 cytokine production. J. Allergy Clin. Immunol. 111: 862-868.
33. + regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis. Br. J. Dermatol. 153: 750-757.
34. Miyara, M., Z. Amoura, C. Parizot, C. Badoual, K. Dorgham, S. Trad, M. Kambouchner, D. Valeyre, C. Chapelon-Abric, P. Debré, et al. 2006. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 203: 359-370. (Pubitemid 43290845)